TransMedics Group, Inc. TMDX
NASDAQ
| 09/30/2026 | 06/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 6.87% | 9.21% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 6.87% | 9.21% | |||
| Cost of Revenue | 9.90% | 5.47% | |||
| Gross Profit | 4.82% | 11.90% | |||
| SG&A Expenses | 6.06% | -8.18% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.21% | 3.47% | |||
| Operating Income | 18.56% | 78.51% | |||
| Income Before Tax | 24.20% | 128.70% | |||
| Income Tax Expenses | 48.80% | 303.68% | |||
| Earnings from Continuing Operations | 16.29% | 100.71% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 16.29% | 100.71% | |||
| EBIT | 18.56% | 78.51% | |||
| EBITDA | 14.47% | 35.64% | |||
| EPS Basic | 15.90% | 99.62% | |||
| Normalized Basic EPS | 23.81% | 127.43% | |||
| EPS Diluted | 14.15% | 102.85% | |||
| Normalized Diluted EPS | 23.83% | 103.34% | |||
| Average Basic Shares Outstanding | 0.32% | 0.57% | |||
| Average Diluted Shares Outstanding | 0.30% | 12.47% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||